Track topics on Twitter Track topics that are important to you
Advanced Dermatology LLC PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Advanced Dermatology LLC articles that have been published worldwide.
We have published hundreds of Advanced Dermatology LLC news stories on BioPortfolio along with dozens of Advanced Dermatology LLC Clinical Trials and PubMed Articles about Advanced Dermatology LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Dermatology LLC Companies in our database. You can also find out about relevant Advanced Dermatology LLC Drugs and Medications on this site too.
This article will help the general physician recognize and manage acute dermatology presentations. This can be challenging for non-dermatology doctors owing partly to the difficulty in providing an extensive dermatology undergraduate education and the lack of exposure to dermatology patients. The problem is further compounded at many hospital trusts because of the lack of on-site dermatology 'on-call'. The general physician must be able to recognize dermatology emergencies in order to provide initial manage...
The number of nurse practitioners (NPs) specializing in dermatology has been rapidly rising. Most dermatology NPs acquire their knowledge and skills through post-master's continuing education, select NP fellowship programs, and on-the-job training. However, the professional competencies for dermatology NPs have not been defined or standardized. Competencies require unique knowledge, skills, and judgment for the care of dermatology patients. A national task force and validation panel was convened to define t...
Until now there was no validated dermatology-specific health-related quality of life (HRQoL) instrument to be used in youngest patients.
Confidence intervals (CIs) offer a complete and intuitive presentation of results and are more informative than p-values. The current prevalence of CI reporting in the dermatology literature has not been reported.
A phase 2 trial comparing talimogene laherparepvec plus ipilimumab vs ipilimumab monotherapy in patients with advanced unresectable melanoma found no differential benefit in progression-free survival (PFS) but noted objective response rates (ORRs) of 38.8% (38 of 98 patients) vs 18.0% (18 of 100 patients), respectively.
Reply to: "S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)".
We read with great interest the guideline for the treatment of cutaneous lupus erythematosus (CLE) elaborated by the European Dermatology Forum in cooperation with the European Academy of Dermatology and Venereology published in the Journal of the European Academy of Dermatology and Venereology in March 2017. A therapeutic guide for CLE is absolutely necessary to decide the best management of our patients. Nevertheless, we would like to point out important aspects regarding the role of laser therapy in pati...
Dermatofibrosarcoma protuberans (DFSP) has the potential for local destruction and recurrence, although it carries a low risk of metastasis. Complete surgical resection with negative margins is considered the gold standard for treatment; however, there are cases that are unresectable owing to tumor extension or size or owing to risk of cosmetic and/or functional impairment. Imatinib treatment has been used for locally advanced or metastatic DFSP.
Recurrence after the discontinuation of Hedgehog pathway inhibitor (HPI) treatment in responding patients with advanced basal cell carcinoma (BCC) is an emerging clinical challenge. A 54-year old female patient presented in 2016 with an histologically proven BCC on the right peri-auricular area, extending to the ear, that was present for 6 years (Figure 1, upper panel). Due to considerable deformity expected with surgery, the patient was treated with vismodegib 150 mg/day. This article is protected by copyr...
Physician burnout is a hot topic today, but what is burnout and who is at risk? In the field of dermatology-one with relatively few emergencies and often modest work hours-does burnout even apply to us? Herein, I provide a working definition of physician burnout and discuss who it affects as well as potential causes in dermatology.
Potassium iodide (KI) is a medication that has been used for decades in dermatology and it is mentioned as a treatment option in all major dermatology textbooks. Yet, there is little recent information on its efficacy. In our study, we wanted to retrospectively evaluate the therapy response to KI in our patients.
The importance of inpatient consultative dermatology is often under recognized and undervalued. A significant need exists as the burden of skin disease in the hospital is great and expertise regarding the recognition and management of uncommon and severe skin disorders is limited outside of the field. In response to this need the concept of a "dermatology hospitalist" was defined and the Society for Dermatology Hospitalists was created in 2009. Over the past decade, the sub-specialty has developed and foste...
Misperceptions have persisted regarding scanning full-field erbium laser that have caused it to be overshadowed by fractional ablative resurfacing. This can lead to sub-optimally treating the periocular and perioral skin. Our report describes the utility of a combined approach of fractional ablative CO2 with full-field erbium ablation for full face rejuvenation. Each laser has a role in creating the optimal outcomes for advanced photoaging in the fewest treatments.